{"news_desk": "National", "print_page": "24", "section_name": "U.S.", "subsection_name": "Politics", "byline": {"original": "By GARDINER HARRIS", "person": [{"rank": 1, "role": "reported", "firstname": "Gardiner", "organization": "", "lastname": "HARRIS"}]}, "abstract": "Drugmaker Pfizer's decision to merge with Allergan and move its headquarters to Ireland has shaken industry lobbyists, who see potential to damage industry and create backlash against it; Obama administration and both Republican and Democratic members of Congress have pressed for tax-code reform that would prohibit practice, known as 'corporate inversion,' that allows companies to pay foreign taxes rather than higher American rates. ", "type_of_material": "News", "word_count": "1169", "lead_paragraph": "Escalating drug prices and now a major company&#8217;s pending move overseas leads to concern about &#8220;too much obvious greed&#8221; in the pharmaceutical industry.", "pub_date": "2015-11-26T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Pfizer\u2019s Plan to Leave U.S. Unsettles Drug Lobbyists", "print_headline": "Pfizer&#8217;s Plan to Leave U.S. Unsettles Drug Lobbyists "}, "snippet": "Escalating drug prices and now a major company&#8217;s pending move overseas leads to concern about &#8220;too much obvious greed&#8221; in the pharmaceutical industry.", "multimedia": [{"height": 126, "url": "images/2015/11/26/us/26lobby-web/26lobby-web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/26/us/26lobby-web/26lobby-web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 412, "url": "images/2015/11/26/us/26lobby-web/26lobby-web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "412", "xlarge": "images/2015/11/26/us/26lobby-web/26lobby-web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/26/us/26lobby-web/26lobby-web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/26/us/26lobby-web/26lobby-web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/26/us/politics/drug-lobbyist-discomfort-over-pfizers-leaving-us.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Relocation of Business", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Corporate Taxes", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Ireland", "name": "glocations"}, {"rank": "6", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Lobbying and Lobbyists", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Susman, Sally (1961- )", "name": "persons"}, {"rank": "9", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "blog": [], "_id": "56565a0b38f0d8310210dd10", "source": "The New York Times"}